Business Context and Reporting Period
This Form 6-K filing by Scinai Immunotherapeutics Ltd. is dated October 15, 2024. The report serves to notify shareholders of an upcoming Annual Meeting of Shareholders scheduled for November 21, 2024, at 4:00 p.m. Israel time. The meeting will be held at the offices of Goldfarb Gross Seligman & Co. in Tel Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this filing. The document focuses solely on the logistics of the shareholder meeting and the incorporation of the Notice and Proxy Statement into existing registration statements.
Guidance, Outlook, and Management Commentary
The filing includes no management commentary on business outlook, risks, contingencies, or unusual items. It strictly details the procedural aspects of the Annual Meeting, including the furnishing of the Notice and Proxy Statement (Exhibit 99.1) and the Proxy Card (Exhibit 99.2) for American Depositary Share holders.
Key Facts for Investor Verification
- Meeting Date: November 21, 2024.
- Meeting Time: 4:00 p.m. Israel time.
- Location: Goldfarb Gross Seligman & Co., One Azrieli Center, Round Tower, Tel Aviv, Israel.
- Voting Materials: Shareholders should review the attached Notice and Proxy Statement (Exhibit 99.1) for voting proposals and procedures.
- Registration Impact: This report is incorporated by reference into the company's Form S-8 and Form F-3 registration statements.